These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34285549)

  • 1. Signature Panel of 11 Methylated mRNAs and 3 Methylated lncRNAs for Prediction of Recurrence-Free Survival in Prostate Cancer Patients.
    Cai J; Yang F; Chen X; Huang H; Miao B
    Pharmgenomics Pers Med; 2021; 14():797-811. PubMed ID: 34285549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexpression Network Analysis Identifies a Novel Nine-RNA Signature to Improve Prognostic Prediction for Prostate Cancer Patients.
    Cai J; Chen Z; Chen X; Huang H; Lin X; Miao B
    Biomed Res Int; 2020; 2020():4264291. PubMed ID: 32953881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy.
    Geybels MS; Wright JL; Bibikova M; Klotzle B; Fan JB; Zhao S; Feng Z; Ostrander EA; Lin DW; Nelson PS; Stanford JL
    Clin Epigenetics; 2016; 8():97. PubMed ID: 27651837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a Multi-RNA-Type-Based Signature for Recurrence-Free Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
    Wang P; Zeng Z; Shen X; Tian X; Ye Q
    DNA Cell Biol; 2020 Apr; 39(4):615-630. PubMed ID: 32105510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy.
    Luan JC; Zhang QJ; Zhao K; Zhou X; Yao LY; Zhang TT; Zeng TY; Xia JD; Song NH
    J Cancer; 2021; 12(12):3715-3725. PubMed ID: 33995646
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of a 5-Gene-Based Scoring System by WGCNA and LASSO to Predict Prognosis for Rectal Cancer Patients.
    Huang H; Xu S; Chen A; Li F; Wu J; Tu X; Hu K
    Anal Cell Pathol (Amst); 2021; 2021():6697407. PubMed ID: 33833937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of methylation-driven genes prognostic signature for recurrence of laryngeal squamous cell carcinoma by integrated bioinformatics analysis.
    Cui J; Wang L; Zhong W; Chen Z; Chen J; Yang H; Liu G
    Cancer Cell Int; 2020; 20():472. PubMed ID: 33005105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of an E2F-related gene signature for predicting recurrence-free survival in human prostate cancer.
    Yang C; Chen L; Niu Q; Ge Q; Zhang J; Tao J; Zhou J; Liang C
    Cancer Cell Int; 2022 Dec; 22(1):382. PubMed ID: 36471446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene signatures predict biochemical recurrence-free survival in primary prostate cancer patients after radical therapy.
    Su Q; Liu Z; Chen C; Gao H; Zhu Y; Wang L; Pan M; Liu J; Yang X; Tian J
    Cancer Med; 2021 Sep; 10(18):6492-6502. PubMed ID: 34453418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
    Li W; Liu J; Zhao H
    Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
    Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
    Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Validation of a Prognostic 5-Protein Signature for Biochemical Recurrence Following Radical Prostatectomy for Prostate Cancer.
    Lv D; Cao Z; Li W; Zheng H; Wu X; Liu Y; Gu D; Zeng G
    Front Surg; 2021; 8():665115. PubMed ID: 34136527
    [No Abstract]   [Full Text] [Related]  

  • 13. A Combined RNA Signature Predicts Recurrence Risk of Stage I-IIIA Lung Squamous Cell Carcinoma.
    Sun L; Li J; Li X; Yang X; Zhang S; Wang X; Wang N; Xu K; Jiang X; Zhang Y
    Front Genet; 2021; 12():676464. PubMed ID: 34194476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel epigenetic signature to predict recurrence-free survival in patients with colon cancer.
    Dai QX; Liao YH; Deng XH; Xiao XL; Zhang L; Zhou L
    Clin Chim Acta; 2020 Sep; 508():54-60. PubMed ID: 32423860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of a six immune-related gene signature for prediction of biochemical recurrence in localized prostate cancer following radical prostatectomy.
    Luan J; Zhang Q; Song L; Wang Y; Ji C; Cong R; Zheng Q; Xu Z; Xia J; Song N
    Transl Androl Urol; 2021 Mar; 10(3):1018-1029. PubMed ID: 33850736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five lncRNAs Associated With Prostate Cancer Prognosis Identified by Coexpression Network Analysis.
    Gong X; Ning B
    Technol Cancer Res Treat; 2020; 19():1533033820963578. PubMed ID: 33084528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant Evaluation and Clinical Prognostic Values of M6A RNA Methylation Regulators in Prostate Cancer.
    Zhang Q; Luan J; Song L; Wei X; Xia J; Song N
    J Cancer; 2021; 12(12):3575-3586. PubMed ID: 33995635
    [No Abstract]   [Full Text] [Related]  

  • 19. An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma.
    Li W; Lu J; Ma Z; Zhao J; Liu J
    Front Genet; 2019; 10():1323. PubMed ID: 32010188
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
    Zhao J; Wang L; Wei B
    Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.